Last reviewed · How we verify
NCT03457857: Microbiome
Evaluation of Two Regimens, With Healthy Male and Female Babies, Ages 3-6 Months Old, Using Various Assessments.
NA trial testing Cleanser in Microbiome in 38 participants. Completed in 11 May 2018.
11 May 2018
Quick facts
| Lead sponsor | Johnson & Johnson Consumer Inc. (J&JCI) |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 38 |
| Start date | 10 January 2018 |
| Primary completion | 11 May 2018 |
| Estimated completion | 11 May 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cleanser — full drug profile →
- Cleanser and Lotion
Conditions studied
- Microbiome — all drugs for Microbiome →
Sponsor
Johnson & Johnson Consumer Inc. (J&JCI) — full company profile →
Who can join
Adults 3 Months to 6 Months, any sex, with Microbiome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is to assess the impact of two skincare regimens on the cutaneous microbiome and skin physiology of healthy male and female infants, ages 3-6 months using clinical, instrumental, D-Squame tape, microbiome and parental assessments over a five-week period.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A randomized clinical study on the effects of emollient use on the developing infant skin microbiome and metabolome.
Capone KA, Friscia DL, Nikolovski J, Telofski LS, et al · · 2023 · cited 10× · PMID 36204776 · DOI 10.1111/exd.14684
Verify or expand the search:
- PubMed search for NCT03457857
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cleanser
Trials testing the same drug.
- NCT06775314 — The Effectiveness and Safety of Cleanser Containing Triethyl Citrate, Pyruvic Acid, Combination Cream Containing Triethy · Phase 3 · not yet recruiting
- NCT03197883 — Assessment of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Wh · NA · completed
- NCT03287791 — A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea · Phase 3 · completed
Other recruiting trials for Microbiome
Currently open trials in the same condition.
- NCT07501455 — Comparison of the Effects of Oral Hygiene Regimens on Clinical, Immunomodulatory, and Microbial Outcomes and Oral Tolera · NA · recruiting
- NCT07439718 — The Effects of an Oral Nutritional Intervention on the Small Intestine Microbiome · NA · recruiting
- NCT07209007 — Dynamics of Dysbiosis in the Skin and Gut Microbiome of Burn Patients · recruiting
- NCT06778083 — STI Prophylaxis and Emergence of Antimicrobial Resistance · recruiting
- NCT06606119 — The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma · recruiting
Other Johnson & Johnson Consumer Inc. (J&JCI) trials
Trials by the same sponsor.
- NCT06852742 — A Study to Evaluate and Compare the Efficacy of Two Facial Creams on Moderately to Severely Photodamaged Skin · NA · completed
- NCT06734299 — A Study to Evaluate Usage of Mineral Sunscreens With Differentiated Whitening Attributes in Multi-Cultural Skin Tones · NA · completed
- NCT06658847 — A Study to Evaluate the Effect of a Topical Retinol on Epigenetic Changes and Expression of Certain Genes in the Skin Us · NA · completed
- NCT06654102 — A Study to Evaluate the Cutaneous Effects of Deep Ultraviolet A +/- High-Energy Visible Blue Light Exposure · NA · completed
- NCT06318637 — Evaluation of the Acceptability and Feasibility of a Bedtime Routine for Neonates · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03457857 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Consumer Inc. (J&JCI)
- Last refreshed: 20 August 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03457857.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing